Featured Videos

Late-Breaking Clinical Trial presented by Dr. Manj Gohel at The VEINS 2024

Moderator: Raghu Kolluri, MD, MS

Panel: Venita Chandra, MD; Yogen Kanthi, MD; Maureen P. Kohi, MD; Gloria Salazar, MD; Eric A. Secemsky, MD, MSc

Originally recorded November 3, 2024.

Late-Breaking Clinical Trial presented by Dr. Julie Bulman at The VEINS 2024

Moderator: Raghu Kolluri, MD, MS

Panel: Venita Chandra, MD; Yogen Kanthi, MD; Maureen P. Kohi, MD; Gloria Salazar, MD; Eric A. Secemsky, MD, MSc

Originally recorded November 3, 2024.

Late-Breaking Clinical Trial presented by Dr. Venita Chandra at VIVA24

Moderator: Eric A. Secemsky, MD, MSc

Panel: J. Fritz Angle, MD; Iris Baumgartner, MD; Marc P. Bonaca, MD, MPH; Patrick Geraghty, MD; Misty Humphries, MD; Brian Pullin; Mehdi Shishehbor, DO, MPH, PhD

Originally recorded November 4, 2024.

Late-Breaking Clinical Trial presented by Dr. Brian DeRubertis at VIVA24

Moderator: Eric A. Secemsky, MD, MSc

Panel: J. Fritz Angle, MD; Iris Baumgartner, MD; Marc P. Bonaca, MD, MPH; Patrick Geraghty, MD; Misty Humphries, MD; Brian Pullin; Mehdi Shishehbor, DO, MPH, PhD

Originally recorded November 4, 2024.

Late-Breaking Clinical Trial presented by Dr. Jay Giri at VIVA24

Moderator: Joshua Beckman, MD

Panel: Misty Humphries, MD; Zola N’Dandu, MD; Krina Patel; Vincent L. Rowe, MD; Eric A. Secemsky, MD, MSc; Nora Tabori, MD

Originally recorded November 5, 2024.

Late-Breaking Clinical Trial presented by Dr. Parag Patel at VIVA24

Moderator: Ehrin Armstrong, MD

Panel: Bryan Fisher, MD; Raghu Kolluri, MD, MS; Jun Li, MD; Lindsay Machan, MD; Misti Malone, PhD; Niten Singh, MD; Peter A. Soukas, MD

Originally recorded November 4, 2024.

In this important VIVA24 session, experts examined variations in care across patient populations, combatting biases, and how we can move toward a better future for all patients.

Moderator: Niten Singh, MD

Panel: Joshua Beckman, MD; Donna Buckley, MD; Bryan Fisher, MD; Elina Quiroga, MD, MPH; Vincent L. Rowe, MD; Margaret Tracci, MD, JD

Recorded November 5, 2024.

Award presenter: Niten Singh, MD
ATLAS award recipient: Peter A. Schneider, MD

After accepting the award, Dr. Schneider presents his ATLAS lecture titled Passionate About Vascular Care: "Growing in an Era of Change and Challenge."

This presentation was recorded on October 31, 2023, during the VIVA conference at Wynn Las Vegas.

Late-Breaking Clinical Trial presented by Dr. Raghu Kolluri at VIVA23

Moderator: Parag J. Patel, MD, MS

Panel: Subhash Banerjee, MD; Jeff Carr, MD; Daniel Clair, MD; Caitlin W. Hicks, MD, MS; Kayla M. Scott, PhD; Jordan R. Stern, MD

Recorded October 31, 2023.

Late-Breaking Clinical Trial presented by Dr. Osamu Iida at VIVA23

Moderator: Sean Lyden, MD

Panel: Marc Bonaca, MD, MPH; Kenneth Cavanaugh, PhD; Venita Chandra, MD; Misty Humphries, MD; Constantino Pena, MD; Eric A. Secemsky, MD, MSc

Recorded October 31, 2023.

Dr. Yogen Kanthi presents "Pharmacotherapy in Preventing and Treating Thromboembolic Disease in Active Malignancy" at The VEINS 2023 as part of the session "All About Blood Clots"

This presentation was recorded on Saturday, October 28, 2023 at Wynn Las Vegas.

Dr. Michael Dake presents the first annual ATLAS Lecture titled "Preparing for the Future: Building a Learning Environment While Addressing Workforce Shortages."

The ATLAS (A Teacher, Leader, And Scholar) Award celebrates the career and impact of physicians who have distinguished themselves as scholars and leaders in their respective vascular fields. They have committed their careers to advancing the care of patients with vascular disorders, and they have taught countless numbers of physicians techniques to expand care across the United States and the world. The VIVA Foundation was proud to honor Dr. Dake as the 2022 ATLAS Award recipient, and we thank him for his innumerable contributions to the field of interventional radiology as a practitioner and educator.

This presentation was recorded on Tuesday, November 1, 2022 at Wynn Las Vegas.

Late-breaking data from the STRIDE and SOUL studies show semaglutide improved symptoms, walking distance, and quality of life for patients with PAD, with SOUL also showing a reduction in adverse limb events. In this 1-hour webinar, the lead authors of both studies joined a panel of multidisciplinary endovascular experts to unpack the implications of these findings, discuss the evolving landscape of medical therapies for PAD, and shared top-line takeaways for clinicians.

Originally broadcast May 21, 2025.

In this clip from VIVA’s recent Data Deep Dive, Dr. Darren McGuire presents new findings from the SOUL study.

Moderator: Joshua Beckman, MD

Panelists: Marc P. Bonaca, MD, MPH; Brian DeRubertis, MD; Daniella Kadian-Dodov, MD; Darren McGuire, MD;

Sahil Parikh, MD; Constantino Peña, MD

Originally broadcast May 21, 2025.

In this clip from VIVA’s recent Data Deep Dive, Dr. Marc Bonaca presents new findings from the STRIDE-PAD study, leading to a spirited conversation on whether all PAD patients should be treated with semaglutide vs real-world limitations and the complexity of treatment decisions.

Watch as leading voices in the vascular field debate the implications of these recent data, and what they could mean for the future of PAD care.

Moderator: Joshua Beckman, MD

Panelists: Marc P. Bonaca, MD, MPH; Brian DeRubertis, MD; Daniella Kadian-Dodov, MD; Darren McGuire, MD; Sahil Parikh, MD; Constantino Peña, MD

Originally broadcast May 21, 2025.

Over the last two years, The VIVA Foundation, the American Venous Forum (AVF), and the American Vein and Lymphatic Society (AVLS) have collaborated to publish a consensus statement on nonthrombotic iliac vein lesions, seeking to address the challenges posed by limited research and to offer clarity to practitioners. A selection of these authors took a closer look at the statements and offered additional insights on the paper’s methodology.

Originally broadcast October 1, 2024.

Bioresorbable scaffolds represent a novel option for treatment of below-the-knee lesions that offer advantages over permanent devices. New data show not only efficacy and safety parity with angioplasty balloon angioplasty, but LIFE-BTK also demonstrated that scaffolds lower BTK limb events.

In this 1-hour webinar, LIFE-BTK trial leaders, a representative from the FDA, and a wound care expert shared their perspectives on the trial, its design, and the ramifications of its findings.

Originally broadcast March 14, 2024.

Funded by Abbott